James O’Dell, M.D
Treating rheumatoid arthritis with a common acne drug

Professor & Residency Program Director
Department of Internal Medicine

James O’Dell, M.D

More than two million Americans suffer pain and stiffness from rheumatoid arthritis. Fortunately, a study led by Dr. James O’Dell in conjunction with the Rheumatoid Arthritis Investigation Network (RAIN) found that minocycline, a common acne drug, provides significant improvement during the early stages of the disease.

Rheumatoid arthritis is an autoimmune disorder that affects more than 2 million Americans. It is a chronic disease that causes pain, stiffness, swelling and loss of function in the joints and inflammation in other body organs. It's estimated that rheumatoid arthritis results in more than 9 million physician visits and more than 250,000 hospitalizations per year. There is no cure for rheumatoid arthritis, so the goal of treatment is to achieve remissions or near remissions.
University of Nebraska 3835 Holdrege Street, Lincoln, Nebraska 68583 | 402.472.2111 | Comments?Follow the University of Nebraska on Twitter
© 2014 University of Nebraska Board of Regents